Outlook Therapeutics
OTLK
$8.64
Share price
-3.14%
Change (1 day)
638.46%
Change (1 year)
Categories
Operating Margin for Outlook Therapeutics (OTLK)
Operating Margin as of May 2024 (TTM): -465.68%
According to Outlook Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -465.68%. At the end of 2019 the company had an Operating Margin of -465.68%.
Operating Margin history for Outlook Therapeutics from 2015 to 2019
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2019 | -465.68% | -57.39% |
| 2018 | -1,092.78% | 8.62% |
| 2017 | -1,006.10% | -43.68% |
| 2016 | -1,786.37% | 90.82% |
| 2015 | -936.15% | 537.36% |
| 2014 | -146.88% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -591.52% | 27.02% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -129.00% | -72.30% | 🇬🇧 UK |
 Novavax NVAX | -149.57% | -67.88% | 🇺🇸 USA |
 Novocure
NVCR | -37.52% | -91.94% | Jersey |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.